Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 13, 2013
The American Association of Pharmaceutical Scientists (AAPS) has established a premier information network for pharmaceutical scientists around the world. In order to have a greater impact in advancing the contributions of the pharmaceutical sciences...
read more
Friday, December 13, 2013
Leading events organiser, UBM Live announces that CPhI Japan is returning for its twelfth year to Tokyo, from the 9th to the 11th April, 2014. The event will once again be co-locating to provide an all-round experience, creating a pivotal meeting-...
read more
Friday, December 13, 2013
Pharmalucence, Inc. (www.pharmalucence.com) today announced that it has entered into an agreement with Lantheus Medical Imaging, Inc. (www.lantheus.com) to serve as a contract manufacturer of DEFINITY® Vial for (Perflutren Lipid Microsphere) ...
read more
Wednesday, December 11, 2013
Marken announced today that their Singapore biological kit-building facility has now been certified to International Standards Organization (ISO) 13485 standards for the storage and distribution of medical devices.
read more
Wednesday, December 11, 2013
PharmSource, the acknowledged authority on bio/pharmaceutical contract manufacturing, has released an extensive
study on the supply and demand for contract injectable manufacturing through 2019. This important analysis
provides invaluable ...
read more
Wednesday, December 11, 2013
Trevigen Inc. has been awarded $252,000 for the Small Business Innovation Research (SBIR) Phase I Contract, 261201300042C, from the National Cancer Institute and the National Institutes of Health (NIH) to develop a tumor-aligned 3D coculture system. ...
read more
Wednesday, December 04, 2013
AAIPharma Services, Corp. (“AAI”), a
leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in
pharmaceutical API development and...
read more
Thursday, November 28, 2013
Xcelience announced today the hiring of Joseph Iacobucci as Vice President of Clinical Supplies and Services. Mr. Iacobucci brings nearly 30 years of experience in clinical packaging and supply services, including 23 years as a Vice President for ...
read more
Wednesday, November 27, 2013
Jim Beach, a veteran health care executive with broad
experience in operations, R&D, marketing and sales, has been named chief operating officer for
Camargo Pharmaceutical Services, a leading drug development organization specializing in the
505(b...
read more
Tuesday, November 19, 2013
Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.
read more
Friday, November 15, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
read more
Friday, November 15, 2013
ordenPharma acquired Ancora Pharmaceuticals, located in Woburn, MA, USA. Ancora’s unique carbohydrate synthesis technology platform and chemistry research facilities perfectly complement CordenPharma’s capabilities in the manufacture and supply of ...
read more
Monday, November 11, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Jesse McCool as Vice President of Microbial Services.
read more
Monday, November 11, 2013
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has received formal approval from the U.S. Food and Drug Administration (FDA) of its supplemental filing for the site transfer of ...
read more
Wednesday, November 06, 2013
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with Opthea Pty Ltd of Melbourne, Australia.
read more